Zydus Life launches vaccine for new strain of influenza virus
Zydus Lifesciences announced the launch of VaxiFlu-4, India's first quadrivalent influenza vaccine, for the 2025 southern hemisphere season.
Zydus Lifesciences announced the launch of VaxiFlu-4, India's first quadrivalent influenza vaccine, for the 2025 southern hemisphere season.
Zydus has supplied 5ml sterile water for injection along with the product but the direction for use states "use 3ml for intramuscular injection and 10ml for intravenous injection"
Zydus lifesciences said that US Food and Drug Administration (USFDA) classified the inspection conducted at its injectables manufacturing facility located at Ahmedabad in March 2024 as OAI